Prima Nexus / Events / 2016

41st Annual Conference of the Malaysian Society for Biochemistry and Molecular Biology (MSBMB)

Prima Nexus sponsored the 41st Annual Conference of the Malaysian Society for Biochemistry and Molecular Biology, held in Kuala Lumpur on 17 and 18 August 2016.

· Conference · Sponsored by Prima Nexus

Delegates seated at long tables in the conference hall, facing a screen and a stage with MSBMB balloon letters
The main hall at Pullman Kuala Lumpur Bangsar during a session of the 41st MSBMB Annual Conference.

The conference

The Malaysian Society for Biochemistry and Molecular Biology (MSBMB) held its 41st Annual Conference over two days at Pullman Kuala Lumpur Bangsar. The chair of its scientific committee was from UCSI University, and the conference treasurer was from the Institute of Systems Biology at Universiti Kebangsaan Malaysia (UKM).

Talks, posters and exhibitors

Sessions were held in the main hall, where speakers presented from a lectern beside the screen. Researchers also showed their work on posters mounted on display boards, and laboratory suppliers showed equipment in an exhibition area.

Prima Nexus as a sponsor

Prima Nexus sponsored the conference in kind, supplying Prima Nexus folders, pens and A5 notepads for the delegates. Today Prima Nexus supports researchers in biochemistry and molecular biology through its ELISA and Luminex services.

More of our work with UCSI, UKM, MSBMB.

About Prima Nexus

Prima Nexus Sdn Bhd is a Malaysian research coordination group founded in 2014. It runs hands-on training for researchers across Malaysia and eight scientific platforms under one roof: proteomics (including ELISA and Luminex multiplex immunoassays), genomics, flow cytometry, stem cell research, animal research, clinical trials, bioinformatics, and regulatory and grant support. More about Prima Nexus.

BiochemistryMolecular biology

Work with us

Planning a workshop, a study or a lab set-up? Talk to us.

We run hands-on training at universities and institutes across Malaysia, and support research teams from a single biomarker panel to a multi-site clinical programme.